A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients

✍ Scribed by Ming-Hua Zheng; Ke-Qing Shi; Zhi-Juan Dai; Chao Ye; Yong-Ping Chen

• Book ID: 113544198
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 136 KB
• Volume: 32
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2010.04.001